Portable retinal imager developer Vasoptic Medical raised $1.5 million in a new round of equity financing, according to an SEC filing posted last week.
The Baltimore, Md.-based company is developing a portable retinal imaging device designed to capture physiological information from the retinal microvasculature.
Vasoptic Medical said that such information can provide a quantitative means of monitoring the progression of various metrics indicative of ophthalmic and systemic disease. T
he company’s initial focus for the device will be on monitoring diabetic retinopathy to prevent vision loss in diabetes patients, according to a the company’s website.
Money in the round came from 1 unnamed source, according to the SEC filing. The 1st sale in the round was noted as March 23.